Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart FailureÅke Hjalmarson, for the MERIT-HF Study Group, Sidney Goldstein et al.|JAMA|2000Cited by 1.4k
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trialMarc S. Sabatine, Terje R. Pedersen, Yehuda Handelsman et al.|The Lancet Diabetes & Endocrinology|2017Cited by 595
Prevalence of hypertension among Indian adults: Results from the great India blood pressure surveySivasubramanian Ramakrishnan, Geevar Zachariah, Kartik Gupta et al.|Indian Heart Journal|2019Cited by 208
Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implicationsGeorge A. Mensah, Prakash Deedwania, Earl S. Ford et al.|Cardiology Clinics|2004Cited by 204
Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional surveyKartik Gupta, Sivasubramanian Ramakrishnan, Geevar Zachariah et al.|International Journal of Cardiology Hypertension|2020Cited by 14